METTLER TOLEDO INTERNATIONAL INC quarterly report, Q2 FY2019

Mettler-Toledo International Inc. — Q2 2019 Form 10-Q

Reporting period: Three and six months ended June 30, 2019. Unaudited results; amounts below are in U.S. dollars unless stated otherwise. The company supplies precision instruments and related services for laboratory, industrial, food retail, and other applications.

Financial performance

  • Q2 revenue: $731.4 million, up 1% reported and 5% in local currencies year over year. Product sales rose 1% reported; service revenue rose 4%.
  • Q2 earnings: Gross profit was $419.5 million (57.4% margin, versus 57.2%); operating income is not separately presented. Earnings before taxes were $155.2 million, up 8%; net earnings were $127.2 million, up 14%. Diluted EPS was $5.06 versus $4.31.
  • First-half revenue and earnings: Revenue was $1.411 billion, up 2% reported and 6% in local currencies. Gross margin was 57.3%, versus 57.0%. Net earnings were $239.0 million, up 17%; diluted EPS was $9.48 versus $7.88.
  • Cash flow: First-half operating cash flow was $225.9 million, compared with $216.8 million. Capital expenditures were $44.7 million versus $61.6 million; operating cash flow less capital expenditures was $181.2 million, compared with $155.2 million. Cash declined $53.7 million to $124.4 million, primarily alongside financing outflows.
  • Debt and liquidity: Total debt was $1.140 billion, including $51.9 million current and $1.088 billion long-term, compared with $1.035 billion at year-end 2018. Cash was $124.4 million; $572.0 million remained available under the credit agreement. The company issued $75 million of 3.91% ten-year notes in June, using proceeds to repay credit-facility borrowings.
  • Capital returns: First-half share repurchases totaled $372.5 million for 539,326 shares, versus $237.5 million for 396,218 shares in the prior-year period. Approximately $1.7 billion remained authorized for repurchases.

Changes versus the prior comparable period

  • Laboratory sales, about 52% of revenue, increased 5% reported in Q2 and first-half, and 8% in local currencies for both periods. Industrial sales were mixed: Q2 declined 1% reported but grew 3% in local currencies; first-half sales rose 1% reported and 5% in local currencies.
  • Retail sales, about 7% of revenue, fell 12% reported in Q2 and 10% in the first half. Management attributed weakness particularly to food retailing in the Americas, unfavorable market conditions, and project timing.
  • Q2 revenue increased in the Americas and Asia/Rest of World but declined in Europe in reported dollars. First-half reported revenue rose 5% in the Americas and 3% in Asia/Rest of World, and fell 2% in Europe.
  • Gross margin improved, with favorable pricing and productivity partly offset by tariffs and initial new-product costs. Service gross margin increased, while product gross margin decreased.
  • Restructuring charges fell to $2.9 million in Q2 and $4.4 million in the first half, from $7.3 million and $11.7 million, respectively.

Outlook, commentary, and risks

  • No specific full-year revenue or EPS guidance is provided in the supplied filing text. Management said first-half results are not necessarily indicative of full-year results and described global market conditions as generally favorable, while cautioning that economic uncertainty is increasing in some regions and emerging markets can change quickly.
  • Management estimated annualized costs from U.S. tariffs on certain China imports at approximately $25 million, assuming a 25% tariff rate, and said it was evaluating mitigation actions. Tariff costs partly offset margin benefits.
  • Currency movements pose risks: management estimated a 1% strengthening of the Swiss franc against the euro could reduce annual pretax earnings by about $1.6–$1.8 million; a 1% weakening of the Chinese renminbi against the U.S. dollar could reduce them by about $1.3–$1.5 million. A 10% weakening of the U.S. dollar against currencies in which debt is denominated could increase reported debt by about $28.9 million.
  • Management expects operating cash flow and available credit to fund anticipated working-capital needs and capital spending for the foreseeable future. It expects $10–$15 million of net investment in new or expanded manufacturing facilities over the next two years, and approximately $25.3 million of employer contributions to non-U.S. pension plans in 2019.
  • Other items to monitor include increased sales and R&D investment, the timing of food-retail projects, and foreign-exchange effects. The company reported no material change in risk factors, no material change in market-risk disclosures, and no legal proceedings expected to have a material adverse effect. Disclosure controls were assessed as effective.

Key investor verification points

  • Assess whether local-currency growth, especially in laboratory products, continues and whether reported results remain affected by currency translation.
  • Track food-retail sales recovery and the effect of project timing and market conditions, particularly in the Americas.
  • Verify actual tariff costs and mitigation progress against management’s estimated annualized cost.
  • Monitor debt, interest expense, cash generation, and the scale of repurchases relative to operating cash flow and investment needs.
  • Review the full-year outlook in subsequent filings; this 10-Q provides no specific full-year sales or EPS target.